Literature DB >> 25106940

The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women.

Praveen Guruvaiah1, Suresh Govatati, Tumu Venkat Reddy, Dakshayani Lomada, Mamata Deenadayal, Sisinthy Shivaji, Manjula Bhanoori.   

Abstract

PURPOSE: The aim of this study was to investigate the association between two common single nucleotide polymorphisms (SNPs) in the vascular endothelial growth factor (VEGF) gene (-460C/T and +405G/C) and polycystic ovary syndrome (PCOS) risk in south Indian women.
METHODS: This study involves clinically confirmed PCOS patients (n = 126) and non-PCOS controls (n = 130) of south Indian origin (Dravidian linguistic group). Genotyping of the VEGF gene -460C/T and +405G/C SNPs were performed by PCR and sequencing analysis. Haplotype frequencies for multiple loci and the standardized disequilibrium coefficient (D') for pairwise linkage disequilibrium (LD) were assessed by Haploview Software.
RESULTS: The frequencies of +405G/G genotype (P = 0.03) and +405G alleles (P = 0.006) were significantly higher in patients compared to controls. Whereas the genotype and allele frequencies of -460C/T SNP were not significantly different between patients and controls. In addition, LD analysis revealed no significant difference between patients and controls.
CONCLUSION: Our findings suggest that the VEGF +405G/C polymorphism may constitute an inheritable risk factor for PCOS in south Indian women.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25106940      PMCID: PMC4171416          DOI: 10.1007/s10815-014-0310-4

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  31 in total

1.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

2.  Higher risk of preeclampsia in the polycystic ovary syndrome. A case control study.

Authors:  M J de Vries; G A Dekker; J Schoemaker
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1998-01       Impact factor: 2.435

3.  VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.

Authors:  Angela M Summers; Beatrice M Coupes; Mary Frances Brennan; Shirley A Ralph; Colin D Short; Paul E C Brenchley
Journal:  Nephrol Dial Transplant       Date:  2005-07-26       Impact factor: 5.992

4.  The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics.

Authors:  J Van Blerkom; M Antczak; R Schrader
Journal:  Hum Reprod       Date:  1997-05       Impact factor: 6.918

5.  Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow.

Authors:  Diaa Eldeen M Abd El Aal; Safwat A Mohamed; Ahmed F Amine; Abdel-Raheim M A Meki
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2005-02-01       Impact factor: 2.435

6.  Evaluation of endothelial function in women with polycystic ovary syndrome.

Authors:  Lior Lowenstein; Amit Damti; Giora Pillar; Susan Shott; Zeev Blumenfeld
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2007-03-19       Impact factor: 2.435

7.  Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression.

Authors:  Yanfen Hu; Sagar Ghosh; Asma Amleh; Wei Yue; Yunzhe Lu; Adam Katz; Rong Li
Journal:  Oncogene       Date:  2005-12-15       Impact factor: 9.867

Review 8.  The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks.

Authors:  C G Solomon
Journal:  Endocrinol Metab Clin North Am       Date:  1999-06       Impact factor: 4.741

9.  The vascular endothelial growth factor (VEGF) +405G>C 5'-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study.

Authors:  Manjula Bhanoori; K Arvind Babu; N G Pavankumar Reddy; K Lakshmi Rao; Krina Zondervan; Mamata Deenadayal; Stephen Kennedy; S Shivaji
Journal:  Hum Reprod       Date:  2005-03-03       Impact factor: 6.918

10.  Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome.

Authors:  R Agrawal; S L Tan; S Wild; P Sladkevicius; L Engmann; N Payne; J Bekir; S Campbell; G Conway; H Jacobs
Journal:  Fertil Steril       Date:  1999-02       Impact factor: 7.329

View more
  10 in total

Review 1.  Polymorphisms of vascular endothelial growth factor and recurrent implantation failure: a systematic review and meta-analysis.

Authors:  Hong Zeng; Lian Hu; Hebin Xie; Wenmin Ma; Song Quan
Journal:  Arch Gynecol Obstet       Date:  2021-04-23       Impact factor: 2.344

2.  Polymorphisms rs2010963 and rs833061 of the VEGF gene in polycystic ovary syndrome.

Authors:  Anna Luiza Silva Almeida Vicente; Alessandra Bernadete Trovó de Marqui; Mariana Kefalas Oliveira Gomes; Alan Vinicius Assunção-Luiz; Marly Aparecida Spadotto Balarin; Sarah Cristina Sato Vaz Tanaka; Elisabete Aparecida Mantovani Rodrigues de Resende; Marco Fábio Prata Lima; Mariangela Torreglosa Ruiz Cintra
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-06-24       Impact factor: 1.712

3.  Vascular endothelial growth factor (VEGFA) gene variation in polycystic ovary syndrome in a Tunisian women population.

Authors:  Assila Ben Salem; Fatma Megdich; Olfa Kacem; Malek Souayeh; Faten Hachani Ben Ali; Sondes Hizem; Faouzi Janhai; Mounir Ajina; Muhammad Abu-Elmagd; Mourad Assidi; Mohammed H Al Qahtani; Touhami Mahjoub
Journal:  BMC Genomics       Date:  2016-10-17       Impact factor: 3.969

4.  Analysis of VEGFA Variants and Changes in VEGF Levels Underscores the Contribution of VEGF to Polycystic Ovary Syndrome.

Authors:  Wassim Y Almawi; Emily Gammoh; Zainab H Malalla; Safa A Al-Madhi
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

5.  Association between VEGF gene polymorphisms (11 sites) and polycystic ovary syndrome risk.

Authors:  Li Huang; Lunwen Wang
Journal:  Biosci Rep       Date:  2020-03-27       Impact factor: 3.840

Review 6.  Association of vascular endothelial growth factor polymorphisms with polycystic ovarian syndrome risk: a meta-analysis.

Authors:  Jiahui Zhao; Da Li; Huaiyun Tang; Lisha Tang
Journal:  Reprod Biol Endocrinol       Date:  2020-03-09       Impact factor: 5.211

Review 7.  Role of Vascular Endothelial Growth Factor (VEGF) in Human Embryo Implantation: Clinical Implications.

Authors:  Xi Guo; Hong Yi; Tin Chiu Li; Yu Wang; Huilin Wang; Xiaoyan Chen
Journal:  Biomolecules       Date:  2021-02-10

8.  Analysis of VEGF gene polymorphisms and serum VEGF protein levels contribution in polycystic ovary syndrome of patients.

Authors:  Lei Bao; Rabbani Syed; Mustafa Sawsan Aloahd
Journal:  Mol Biol Rep       Date:  2019-08-05       Impact factor: 2.316

9.  Interactions of smoking with rs833061 polymorphism on the risk of non-alcoholic fat liver disease in Hubei Han population: a preliminary case-control study.

Authors:  Pengbo Wu; Yonglong Hua; Shiyun Tan; Ming Li; Shu Yongxiang; Guo Fang
Journal:  Iran J Basic Med Sci       Date:  2015-11       Impact factor: 2.699

Review 10.  Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India.

Authors:  Mohammad Ashraf Ganie; Vishnu Vasudevan; Imtiyaz Ahmad Wani; Mohammad Salem Baba; Tasleem Arif; Aafia Rashid
Journal:  Indian J Med Res       Date:  2019-10       Impact factor: 2.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.